Crescent Biopharma gains rights to a Kelun-Biotech antibody drug conjugate it plans to test in combination with its lead cancer drug, a bispecific antibody designed to block PD-1 and VEGF. Separately, Crescent raised $185 million in a private placement to support its clinical trial plans. The post Crescent Bio Expands Its Cancer Drug Combo Ambitions…
Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be screened end up never being tested. Lucid Diagnostics is trying to solve this problem by selling a quick, office-based diagnostic. The post This Pill-Size Diagnostic Seeks to Prevent Thousands of Esophageal Cancer Deaths appeared…
Perhaps, if the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act becomes law. The bill just recently passed the House of Representatives. Newsweek summarizes the bill’s provisions as follows: The bill would increase Dependency and Indemnity Compensation benefits by 1.5 percent over two years. Those payments are provided by the Department of Veterans Affairs (VA) to…
In 2011, National Institutes of Health (NIH)-funded discoveries contributed $69 billion to the nation’s gross domestic product (GDP) and supported seven million jobs. In 2020 alone, the US biomedical and pharmaceutical private sector generated more than $1.4 trillion in economic output. From Reece et al. (Health Affairs 2025) In addition to economic output, private-sector R&D…
“On Feb. 25, I voted yes on a budget resolution that protects Social Security, Medicare, and Medicaid while cutting some spending elsewhere.” Rep. Nick LaLota (R-N.Y.), in a YouTube video posted March 4, 2025 On Feb. 25, Rep. Nick LaLota (R-N.Y.) voted in favor of a House budget resolution that calls for sharp cuts in…
KalVista Pharmaceuticals’ Ekterly is now FDA approved for treating acute swelling attacks from hereditary angioedema. The KalVista tablet provides an alternative to injectable or infused HAE medications from companies such as Takeda Pharmaceutical and CSL Behring. The post KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease appeared first on MedCity…
The path to scalable AI in healthcare will not be defined by a single breakthrough or technology. It will be shaped by the industry’s ability to address the foundational challenges that have existed for decades. The post Healthcare Doesn’t Have an AI Problem — It Has a Readiness Problem appeared first on MedCity News.
According to Experian Health’s State of Claims 2024 survey, missing coverage is the top reason for healthcare claim denials for almost a fifth of providers. However, the issue isn’t just about whether a patient is insured — four in ten providers worry about insurance companies paying out even where patients have active coverage. Constantly changing…
El gobernador de California, Gavin Newsom, que aspira a presentarse en las elecciones presidenciales, ha enfurecido tanto a demócratas como a republicanos por su posición sobre la atención médica para los inmigrantes en su estado. La situación revela el delicado camino político que tiene por delante. Por segundo año, el demócrata pidió a los legisladores…